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http:WHAT THIS PAPER ADDS
Ultrasonic assessment of abdominal aortic aneurysms has traditionally been conﬁned to two-dimensional (2D)
imaging. Determination of a centerline and diameter assessment perpendicular to this line has been the gold
standard by 3D CT. We present a novel 3D ultrasound method capable of measuring the maximum diameter of
the residual sac perpendicular to the centerline herby reducing the well known discrepancy.Objectives: Discrepancy between maximum diameters obtained with two-dimensional ultrasound and computed
tomography (CT) after endovascular aneurysm repair (EVAR) is well known. The maximal diameter is ideally
measured perpendicular to the centerline, a methodology so far only feasible with three-dimensional (3D) CT and
magnetic resonance angiography (MRA). We aimed to investigate the agreement between 3D ultrasound and 3D
CT and to determine reproducibility measures.
Methods: Prospective study comparing 3D ultrasound with 3D CT in 124 consecutive patients seen 3 or 12 month
after EVAR.
Results: Replacing 2D with 3D ultrasound, the mean difference was improved from 6.0 mm to 1.3 mm
(p < .001), and the range of variability was reduced from 9.4 mm to 6.6 mm (p ¼ .009) using 3D CT as the gold
standard. The mean difference between 3D ultrasound and 3D CT maximum diameter of the residual sac
was 1.3 mm with upper and lower limits of agreement of 5.2 mm and 7.9 mm, respectively. Reproducibility
measures of 3D ultrasound were 4 mm.
Conclusion: 3D ultrasound correlate signiﬁcantly better to 3D CT than the currently used 2D ultrasound method
when assessing maximum diameter of the residual sac after EVAR, and reproducibility measures were within
clinical acceptable values.
 2013 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Interobserver variationINTRODUCTION
The size of the residual sac is an important parameter after
endovascular aortic repair (EVAR) since expansion could
imply incomplete aneurysm exclusion and treatment failure,
whereas shrinkage and stability indicate operative suc-
cess.1,2 Graft-related complications continue to be reported
for as long as 8 years after EVAR, thus life-long surveillance
is mandatory.3 Besides being the gold standard in assess-
ment of residual sac diameter, dynamic computed tomo-
graphic angiography (CTA) has a high sensitivity forrresponding author. K. Bredahl, Department of Vascular Surgery,
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//dx.doi.org/10.1016/j.ejvs.2013.09.012endoleak detection and is therefore the most frequently
used modality in EVAR surveillance.1 Accurate diameter
assessment is obtained perpendicular to the centerline of
the aorta on a three-dimensional reconstructed CT (3D
CT).1,2 EVAR surveillance protocols based on ultrasound are
nevertheless emerging because of the risk of contrast-
induced nephropathy and radiation associated with the
use of CTA and the acceptable ability of ultrasound to
detect endoleaks.1,2,4 The maximum diameter obtained by
ultrasound is systematically underestimated compared with
measurements obtained from CTA.5,6 Current two-
dimensional ultrasound (2D US) and CT methods (2D CT)
are both associated with difﬁculties measuring the
maximum diameter perpendicular to the centerline.7 Ul-
trasound measurements are less affected by angulations of
the aneurysm.8 2D CT measurements, however, can be
made from the entire circumferential wall of the aneu-
rysms, whereas the ultrasound reﬂection is strongest from
526 K. Bredahl et al.the anterior and posterior aortic wall. Care must be taken
with the expansion of the residual sac, especially if sur-
veillance is changed from a CT-based to an ultrasound-
based protocol. 3D ultrasound technology has recently
emerged as an alternative, and likewise CTA technology. The
principle of 3D reconstruction allows the maximum diam-
eter perpendicular to the centerline of the aneurysm to be
measured.
We aimed to determine the accuracy of 3D ultrasound
and 2D ultrasound using 3D CTA as the gold standard, and,
secondly, to determine the reproducibility of 3D ultrasound.
MATERIALS AND METHODS
Patients and study design
All consecutive patients scheduled for standard EVAR sur-
veillance at 3- or 12-month follow-up in the period from
August 2011 to July 2012 were prospectively enrolled into
the study after giving informed consent. The study was
approved by the Regional Ethical Committee (H-2e2011e
016).
All patients were initially treated at our institution using
the same EVAR device (Zenith stent-grafts, Cook Medical
Inc., Bloomington, IN, USA).
All patients had CTA, plain abdominal X-ray, and an
ultrasound investigation including 2D examination and 3D
acquisitions. For each patient four maximal aneurysm di-
ameters were assessed and compared: 2D ultrasound, 3D
ultrasound, 2D CT and 3D CT (Fig. 1). We used the maximal
diameter obtained by 3D CT as the gold standard.
If patients were seen at both 3- and 12-month follow-up
during the study period we only included examinations
obtained at the ﬁrst visit.
A subset of the patients included in this study has pre-
viously been described in a methodology study introducing
volume estimation of the residual sac.9
Ultrasound imaging
Patients were not instructed to fast but had 10 minutes of
rest before the examinations. One physician (KB) experi-
enced in vascular ultrasound (>1,000 vascular ultrasound
investigations) performed all investigations with the patient
in supine position using the ultrasound system (Philips iU22
Ultrasound System, Philips Healthcare, Bothell, WA, USA).
First, the 3D ultrasound acquisition was performed fol-
lowed by the traditional 2D ultrasound examination
including endoleak check. Then the same operator per-
formed a second 3D ultrasound acquisition used for intra-
operator assessment. Finally, in cases used for interoperator
assessment, a senior consultant (JE) experienced in vascular
ultrasound (>15 years’ experience in vascular ultrasound)
performed a comparative 3D ultrasound acquisition.
3D ultrasound. The 3D ultrasound acquisition was per-
formed with a commercially available 3D transducer (X6-1
xMATRIX, Philips Healthcare). The maximum cross-sectional
diameter was determined and assisted by dual-plane im-
aging keeping the boundaries of the residual sac within thescan ﬁeld of view. 3D acquisition consists of an electronic
sweep acquiring multiple images simultaneously in both
longitudinal and transverse directions. During breath-hold,
the acquisition was completed within approximately 1 sec-
ond, with the transducer in a stable ﬁrm position. No
diameter information potentially biasing the 2D measure-
ment was displayed during the 3D ultrasound acquisition.
2D ultrasound. The 2D ultrasound investigations were all
performed blinded to the results of 2D CT, 3D CT, and 3D
ultrasound diameter measurement with a 5-MHz curved
array transducer (C5-1, Philips Healthcare). As part of a
standard ultrasound EVAR surveillance scan, the abdominal
aorta was interrogated from the superior mesenteric artery
to the level of the aortic bifurcation. Identifying the greatest
section of the residual, the transducer was tilted from side
to side so that the maximal diameter was measured from
the leading edge of the adventitia of the anterior wall to the
leading edge of the adventitia on the far wall in transverse
view (Fig. 1A).10 In order to correct for obliquity in the
sagittal plane, the measurement obtained in the transverse
plane had to correlate within 3 mm of the measurement
performed in longitudinal imaging.Computed tomography
Biphasic acquisition (unenhanced and contrast-enhanced
with bolus tracking) was performed using a helical 64-slice
CT scanner (Toshiba Medical Systems Ltd, Crawley, UK).
Detector conﬁguration was 0.5  64 (collimation ¼ 32 mm)
with a pitch of 0.8. A bolus dose of 80 mL of non-ionic
iodinated contrast medium (Iohexol 350 mg I/mL, Omni-
paque; GE Healthcare Denmark A/S, Copenhagen, Denmark)
was injected into an antecubital vein at a rate of 3 mL/
second. Scan reconstructions were performed with a slice
thickness and increment of 3 mm.
The 2D CT maximal diameter was measured from outer
to outer circumferential wall in any direction by an expe-
rienced radiologist (MT) (>1,000 EVAR CT evaluations),
blinded to the results of ultrasound and 3D CT, using a PACS
system (Agfa Impax 5.2, Agfa-Gevaert NV, Mortsel, Belgium)
allowing assessment in both the native axial CT slices and in
the multiplanar reconstructions (sagittal and coronal plane)
(Fig. 1B). In cases of tortuosity the diameter was measured
perpendicular to the direction of tortuosity.
3D reconstruction and diameter assessment for ultrasound
and CT. Paired ultrasound acquisitions and contrast-
enhanced CT images were analysed in dedicated 3D inter-
active software (AAA_prototype, version 1.0, Medisys, Phi-
lips Research, Suresnes, France) with an interpolated
interval of at least 14 days.
On the ultrasound and CT acquisitions, the residual sac,
including the stent-graft, was semi-automatically delineated
using the inner vessel wall with the 3D interactive seg-
mentation technique.11 It took between 15 and 30 minutes
to segment the 3D ultrasound acquisition.
For both modalities, the centerline of the residual sac
was automatically generated between two manually
Figure 1. The maximal diameter obtained by the four used imaging methods. (A) Two-dimensional (2D) ultrasound; (B) 2D computed
tomography (CT); (C) three-dimensional (3D) ultrasound; (D) 3D CT; (E) the 3D model created after segmentation of 3D ultrasound
acquisition or axial CT slices presented with a green centerline between the aortic neck and aortic bifurcation, and a blue contour showing
the section including the maximal diameter.
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of the sac (Fig. 1E). Finally, the maximum 3D ultrasound and
3D CT diameter perpendicular to the centerline was
generated from inner to inner vessel wall.Inter- and intraoperator variability
3D ultrasound interoperator variability. Patients (n ¼ 22)
were selected by their concurrent presence on weekdayswhen both operators (KB and JE), mutually blinded, were
available and were rescanned a few minutes after by the
second operator (JE), who afterwards independently ana-
lysed his own 3D acquisitions in the 3D software.
3D ultrasound intraoperator variability. In order to make
the intraoperator assessment as mutually blinded as
possible, the conventional EVAR surveillance protocol,
including 2D ultrasound scan and physical examination, was
Table 1. The mean residual sac diameter obtained by the four
imaging methods and the associated mean difference from
three-dimensional (3D) computed tomography (CT), the gold
standard.
Imaging
method
Mean diameter
(mm)
Mean difference 
range of variability
from 3D CT (mm)
p*
3D CT 60.8 (38.9e82.7) 0  0 NA
2D CT 61.5 (39.9e83.1) 0.7  6.0 .623
3D ultrasound 62.2 (39.1e85.2) 1.3  6.6 .368
2D ultrasound 54.8 (34.6e75.1) 6.0  9.4 .002
*Values relate to comparison of means with 3D CT.
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the ﬁrst and second 3D ultrasound acquisition.
The two 3D acquisitions were then analysed in the 3D
interactive software with time intervals of at least 14 days.
3D CT interoperator variability. The interoperator range of
variability (ROV) of the maximal CT diameter perpendicular
to the centerline was determined between two operators
(AL and KB) familiar with the 3D software, who indepen-
dently assessed the CT scans of all patients (n ¼ 28)
enrolled during the ﬁrst 3 months of the study.
STATISTICS
The maximal residual sac diameter was measured with four
imaging techniques and was expressed as the mean  95%
conﬁdence interval (95% CI) given by 1.96  standard de-
viation of the mean (SD). To compare means we used the
paired Student’s t test.
Comparison of residual sac measurements were repre-
sented in a BlandeAltman plot, where discrepancy of
paired measurement on the same subject were plotted
against the average outcome, showing the mean difference
and the upper and lower limits of agreements given by the
mean difference  the ROV. The ROV was deﬁned as
1.96  SD of the mean difference.12 When evaluating a
method’s accuracy, it is not sufﬁcient only to assess the
mean difference from the gold standard, which may be
different simply due to different physical properties asso-
ciated with CTA and ultrasound. Hence, observed differ-
ences in ROV between methods were tested for
homogeneity using Levene’s test.
All statistical analyses were performed by SAS v. 9.3 (SAS
Institute Inc., Cary, NC, USA).
RESULTS
Patients and technical success rate
In total, 124 patients had paired ultrasound and CT exam-
inations at 3 months (n ¼ 72) or at 12 months (n ¼ 52)
following EVAR. Insonation was impossible due to bowel
gas in four patients, and in one patient having an aorticebi-
iliac aneurysm, the abdominal component could not be
isolated from the iliac aneurysms making the 3D ultrasound
reconstruction impossible, leaving an overall technical suc-
cess rate of 3D ultrasound of 96% (119/124). Patients
having aorticeiliac aneurysms (n ¼ 5) and aorticebi-iliac
aneurysms (n ¼ 3) were included if it was possible to isolate
the abdominal component in the 3D reconstructions. We
observed no patients having claustrophobia or being unable
to cooperate, no patients refused to participate in this
investigation, and no adverse events were observed after
CTA or ultrasound.
We enrolled 13 females and 106 males with a mean age
of 78 years (range 57e90 years) and median body mass
index of 24 (range 16e41) kg/cm2. The mean maximum
preoperative aneurysm diameter obtained with 2D CT was
63.8 (95% CI 44.9e82.6). There were 12 patients with an-
eurysms < 55 mm, of which four had symptomatic non-ruptured aneurysms; six female patients women and two
male patients had asymptomatic aneurysms of 54 mm and
53 mm with more than 5 mm of growth since last visit. The
EVAR device was bifurcated in 87% (n ¼ 104), aorto-uni-iliac
in 12% (n ¼ 14), and a fenestrated endograft was used in
1% (n ¼ 1) of the cases. One patient seen at 12 months
after Palmaz-stent deployment due to proximal sealing
defect had a growing sac. Growth and type I leak were
equivalently identiﬁed on CTA and ultrasound. Type II leaks
were present in 14% (n ¼ 17) of the patients, of which 15
had a stable sac and two had sac shrinkage. No patients
were observed with the combination of type II leak and
increasing maximum diameter.Maximal residual sac diameter
2D and 3D ultrasound and 2D CT compared with 3D CT. The
mean maximum residual sac diameter obtained with 3D CT,
2D CT, 3D ultrasound, and 2D ultrasound was 60.8 (95% CI
38.9e82.7) mm, 61.5 (95% CI 39.9e83.1), 62.2 (95% CI
39.1e85.2), and 54.8 (95% CI 34.6e75.1), respectively.
The mean differences  ROV of 2D CT, 3D ultrasound,
and 2D ultrasound compared with 3D CT
were 0.7  6.0 mm, e1.3  6.6 mm, and 6.0  9.4 mm,
respectively. Only the mean maximum diameter obtained
with 2D ultrasound was more variable than the mean
diameter obtained with 3D CT (p ¼ .002), being the gold
standard (Table 1 and Fig. 2). Furthermore, when measuring
the maximum diameter using 3D ultrasound instead of 2D
ultrasound compared with 3D CT, the ROV was reduced to
6.6 mm from 9.4 mm (p ¼ 0.009).
When comparing 3D ultrasound and 2D CT using 3D CT as
the gold standard, neither the mean difference nor ROV
of 1.3  6.6 mm performed with 3D ultrasound was
different from that performed with 2D CTof 0.7  6.0 mm
(mean difference, p ¼ .13) (ROV, p ¼ .053).
When analysing 3D CT versus 3D ultrasound and
increasing mean aneurysm diameter, a minimal negative
slope of the linear regression line was observed
(slope ¼ 0.0535, p ¼ .0487). In contrast, the linear
regression line of 3D CT versus 2D ultrasound had a positive
slope (slope ¼ 0.0823, p ¼ .0490) (Fig. 2).
Linear regression showed that the absolute difference
between paired 3D ultrasound and 3D CT measurements
slightly deteriorated with increasing preoperative diameter
(slope ¼ 0.052, p ¼ .0146) and the diameter
Figure 2. The performance of three-dimensional (3D) ultrasound and two-dimensional (2D) ultrasound estimated against 3D computed
tomography (CT) being the gold standard. (A) The agreement between the maximum diameter obtained by 3D CT and 3D ultrasound. (B)
The agreement between the maximum diameter obtained by 3D CT and 2D ultrasound. LoA ¼ Limits of Agreement.
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The comparability deteriorated by 0.5 mm with an increase
of 1 cm of either the preoperative diameter or the diameter
obtained at inclusion. Thus, having preoperative residual
sacs of 5.5 cm and 7.5 cm the absolute difference between
paired 3D ultrasound and 3D CT measures increased from
2.4 mm to 3.4 mm.
Comparing the maximum diameters obtained with 3D
ultrasound and 3D CT the discrepancy was less than 5 mm
in 87% (n ¼ 103) of the cases. The remaining 13% (n ¼ 16)
of patients were further assessed. The main reasons for
the larger discrepancy, was imprecise segmentation of the
lateral vessel wall leading to overestimation of the ultra-
sound measure (n ¼ 8), shadowing of the posterolateral
vessel wall due to a close positioned stent-graft (n ¼ 1),
poor image quality in the distal and proximal range of the
scan ﬁeld leading to erroneously deﬁned endolimb ex-
tremities (n ¼ 4), retroperitoneal ﬁbrosis leading to
overestimation of the ultrasound assessment (n ¼ 1),Figure 3. The reproducibility of three-dimensional (3D) ultrasound. (A) In
3D ultrasound acquisition and the following segmentation. (B) Intraop
sound acquisitions obtained and handled by the same operator.inclusion of the cava vein (n ¼ 1), and compression of the
residual sac against the corpus vertebrae by the transducer
(n ¼ 1).
2D and 3D ultrasound compared with 2D CT. When 2D
ultrasound was compared with 2D CT, representing the
most commonly used imaging methods in clinical practice,
we observed a mean difference of 6.7  9.8 mm between
the two. Replacing 2D ultrasound with 3D ultrasound the
mean difference was reduced to 0.6 mm (p < .001) but
the ROV of 9.2 mm was unchanged (p ¼ .687).
Inter- and intraoperator reproducibility
3D ultrasound reproducibility. The mean maximal diameter
difference between two operators performing and assessing
their own acquisition was 0.1 mm, which was not
different from the mean difference obtained between two
acquisitions performed and assessed by the same operator
of 0.7 mm (p ¼ .312) (Fig. 3).teroperator variability, where both operators performed their own
erator variability, the difference between two different 3D ultra-
530 K. Bredahl et al.The 3D ultrasound interoperator ROV was 4.4 mm, which
was not different from the 3D ultrasound intraoperator ROV
of 3.9 mm (p ¼ .239).
Linear regression line of differences showed that neither
the interoperator (slope ¼ 0.1121, p ¼ .0664.) nor the
intraoperator (slope ¼ 0.0696, p ¼ .2572) variability was
inﬂuenced by increasing residual sac size.
3D CT reproducibility. The mean difference between the
ﬁrst and second operator evaluating the same CT scan
(n ¼ 28) was 0.1 mm and the ROV was 2.1 mm, which
was smaller than the interoperator ROV of 3D ultrasound
(p < .001). Linear regression showed that the 3D CT
interoperator variability was not inﬂuenced by increasing
residual sac size (p ¼ .6947).
DISCUSSION
The maximal diameter of the residual sac after EVAR can be
measured more accurately using 3D ultrasound instead of
2D ultrasound according to our study. Not only was the ROV
reduced by one-third but the mean difference from the gold
standard, 3D CT, was close to zero. Finally, the reproduc-
ibility of 3D ultrasound was approximately 4 mm, which we
believe is acceptable for clinical use.
To our knowledge, no studies assessing the maximum
abdominal aortic aneurysm diameter using 3D ultrasound
has been published. Until now, studies evaluating the
agreement between ultrasound and CT have been conﬁned
to the use of 2D ultrasound. These studies reported that the
mean difference between CTA and ultrasound ranged from
1.3 mm to 3.9 mm and the variability ranged from 10 mm
to 12.2 mm.5,6 In this context, our 3D ultrasound results are
most promising, as the ROV was reduced to 6.6 mm and the
mean difference was only 1.3 mm.
The 3D ultrasound interoperator ROV in our study was in
line with the reported reproducibility measures of 2D ul-
trasound of abdominal aortic aneurysm ranging from 2 to
10 mm.13 The reported range of reproducibility measures of
2D ultrasound was, however, restricted to anteroposterior
measurement. Since the main part of previous conducted
reproducibility studies regarding 2D ultrasound were moti-
vated by the set up of screening programmes, mainly small
aneurysms were included in these studies where incorrect
angle of insonation is less critical than measurement of
large aneurysms.14 In this context, it is important to notice
several challenging factors only present in EVAR patients.
First, the residual sacs are often large; however, linear
regression did not show that increasing residual sac size had
a signiﬁcant effect on the 3D ultrasound reproducibility
measures. On the other hand, the difference between 3D
ultrasound and the gold standard was slightly increasing
with increasing residual sac size. Second, aorta and the
residual sac are remodelled after endovascular therapy,
presenting an irregular and thrombotic post-interventional
sac and a centrally located EVAR device making insona-
tion of the posterior vessel wall challenging.
Ultrasound investigations of patients undergoing EVAR
surveillance programmes have until recently been conﬁnedto 2D assessment, while centerline-determined diameter
only has been possible using CTA and a dedicated 3D
workstation, being the gold standard.2 The demonstrated
better agreement between 3D ultrasound and 2D and 3D CT
when using 3D technology has the potential to reduce the
risk of neglecting real expansion of the residual sac in
ultrasound-based EVAR surveillance.
Recent developments in radiation-reduced dual-energy
CTAs have been reported and MR protocols are shown to
be more sensitive than CTA.15,16 Despite this, institutions
with trained ultrasound personal intend to replace CTA
with ultrasound in their EVAR surveillance protocol due to
the risk of contrast-induced nephropathy associated with
CTA. Moreover, using ultrasound the physician has the
possibility to inform the patient immediately in the out-
patient’s clinic (one-visit clinic), and. dependent on local
arrangements, the availability and associated cost may
favour ultrasound instead of MR/CTA. Moreover, some
EVAR devices with stainless steel, as used in this study, are
MR incompatible.
For clinical use, however, 3D ultrasound still has some
challenges to overcome. The segmentation process involves
a learning curve and is time consuming explaining why 3D
ultrasound at our institution is still considered a research
tool. Nevertheless, future improvement of the software is
expected, including automatic and faster 3D segmentation,
and within some years we foresee 3D ultrasound to be an
important complementary imaging modality for accurate
size estimation in “radiation-free EVAR surveillance”. This,
however, demands solid longitudinal follow-up data and our
future results may conﬁrm or reject that 3D ultrasound does
not miss any growing residual sacs that were otherwise
diagnosed by CTA.
Since most institutions use CTA, especially within the ﬁrst
year, the essential question is whether ultrasound can
replace CTA in EVAR surveillance which includes endoleak
detection for which we consider the image quality of the
matrix transducer to be inadequate. Contrast-enhanced 2D
ultrasound is promising, and therefore, in parallel to this
study, we are trying to show that endoleaks can be detected
equivalently compared with CTA. Till then, we still consider
conventional 2D ultrasound in trained hands to be an
effective image modality checking uncomplicated EVAR
cases without growth or endoleaks seen after 1 year.
Abdominal aortic aneurysm is a potential life-threatening
surgical condition where size is a critical determinant, not
only regarding EVAR surveillance. In the surveillance of
small asymptomatic aneurysms, it is well known that 2D
ultrasound tends to underestimate aneurysm size, which is
why aneurysms approaching 5 cm in diameter on ultra-
sound often are referred to CTA.17,18 Accurate correlation
between these image modalities would rationalize the need
for CTA. Whether 3D ultrasound imaging provides better
reproducibility measures for small, native abdominal aortic
aneurysms is a matter of future research, but we would
expect that the absence of the stent-graft would improve
the signal-to-noise ratio and reﬂection of the vessel wall
and thus improve the results.
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mogeneous population in terms of anatomical classiﬁcation,
conformed logistics, that is the same type of EVAR device
inserted, ultrasound investigations performed by one
operator, and CTA scans assessed by a single operator. Poor
2D images, disturbed by bowel gas or calciﬁcation, may to
some extent be compensated by the high number of frames
and different beam angles that the new 3D ultrasound
technique provides. Obviously, we recognize that the same
high technical success rate may be difﬁcult to reproduce in
a clinical setting.
The 3D CT reproducibility was superior to the 3D ultra-
sound reproducibility. This is presumably in part because
the same CTA acquisition was used twice in contradiction to
the 3D ultrasound reproducibility examinations where two
different acquisitions were used. To make two CTA acqui-
sitions is simply not ethical due to the risk of renal
impairment and the radiation dose exposure to the patient.
We, nevertheless, recognize that a better deﬁnition of the
lateral wall on CTA than ultrasound is of great importance,
emphasizing that delineation of the lateral vessel was by far
the most critical step involved using 3D ultrasound. This is
supported by the outliers, where we observed imprecise
lateral wall segmentation and thereby lack of a smooth 3D
shape.
On the other hand, the integration of the lateral wall in
3D ultrasound is one of the strengths and may very well
explain the improved agreement with 2D and 3D CT. In the
transverse plane, the reﬂection from the lateral vessel wall
in 2D ultrasound can be poor. For these reasons 2D ultra-
sound measures are, opposed to 2D CT measures, more
valid when obtained from the anterior to the posterior wall.
In cases where the maximum diameter was located in the
coronal plane from “side to side”, the operator tried to
adjust for this by tilting the transducer (see Fig. 1A) but the
ideal coronal plane could be difﬁcult to achieve using 2D
ultrasound. This detail may lead to less optimal agreement
with 3D CT in cases where the maximum diameter is in the
coronal plane. The poorer reﬂection from the lateral vessel
is no different using 3D ultrasound, but the integration of
multiple ultrasound frames instead of one and reconstruc-
tion of a centerline tends to adjust for this, which means
that the cross-section evaluated on 3D CT and ultrasound
are more alike.
Since the operators were vascular surgeons and angiol-
ogists familiar with the purpose of the study, it may have
been relevant to assess the performance of an independent
radiologist, which we did not.
Finally, the 3D ultrasound and 3D CT segmentation de-
pends on the inner vessel wall whereas the radiologist use
outer-to-outer wall for traditional 2D CT measurements. In
2D ultrasound, assessment was made from the leading edge
of the adventitia on the anterior wall to the leading edge of
the adventitia on the far wall. The reason for using inner
vessel when comparing 3D CT and 3D ultrasound was that
the 3D software depends on distinct differences in grey-
scale; differences being most evident over the boundary
“aortic-lumen/inner-wall”. Using inner to inner wall in 2Dultrasound would result in an even smaller mean maximal
diameter, and therefore and even worse agreement with 3D
CT could be expected.
In conclusion, we introduce a new 3D ultrasound method
to measure the maximum diameter of the residual sac after
EVAR perpendicular to the centerline with improved
agreement with 3D CT and acceptable reproducibility.
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